Corsalex, Inc. Company Profile, Contacts & Intelligence
Corsalex, Inc. Overview
Corsalex’s mission is to identify, fund, and develop promising projects to treat C9orf72 ALS/FTD. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating adult-onset neurodegenerative diseases. Genetic analysis has revealed the hexanucleotide repeat expansion (HRE) disorder C9orf72 as the most common cause of familial ALS/FTD (C9-ALS/FTD). Corsalex is a joint venture between KCK and Panorama Research. Led by Dr. James Larrick, a biomedical entrepreneur with an international reputation and over 30-year career in biotechnology, and backed by KCK, the Company hopes to spur innovation and advance meaningful interventions for this devastating disease.
- Headquarters
- Cupertino, California, United States
- Website
- www.corsalex.com
- Industry
- Biotechnology Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Corsalex, Inc. Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Corsalex, Inc. People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Compare Similar Companies to Corsalex, Inc.
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| BioSpace | Internet News | 144 | View company |
| Verge Genomics | Biotechnology Research | 54 | View company |
| Sarafan ChEM-H | Stanford University | Research | 51 | View company |
| SilverRide | Health And Human Services | 51 | View company |
| Panorama Research | Market Research | 8 | View company |
| AmyGo Solutions | Biotechnology Research | 5 | View company |
| Yale Pathology | Higher Education | 4 | View company |
| Fossiliontech | Biotechnology | 3 | View company |
| CSHL Meetings & Courses | Research Services | 1 | View company |
| X-37 | Pharmaceutical Manufacturing | 1 | View company |